- Home
- VNDA vs BRT Comparison
VNDA vs BRT Comparison
Compare VNDA & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- BRT
- Stock Information
- Founded
- VNDA 2002
- BRT 1972
- Country
- VNDA United States
- BRT United States
- Employees
- VNDA N/A
- BRT N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- BRT Real Estate Investment Trusts
- Sector
- VNDA Health Care
- BRT Real Estate
- Exchange
- VNDA Nasdaq
- BRT Nasdaq
- Market Cap
- VNDA 261.7M
- BRT 291.9M
- IPO Year
- VNDA 2006
- BRT N/A
- Fundamental
- Price
- VNDA $4.55
- BRT $15.73
- Analyst Decision
- VNDA Strong Buy
- BRT Strong Buy
- Analyst Count
- VNDA 3
- BRT 1
- Target Price
- VNDA $15.33
- BRT $21.00
- AVG Volume (30 Days)
- VNDA 362.5K
- BRT 24.2K
- Earning Date
- VNDA 07-30-2025
- BRT 08-05-2025
- Dividend Yield
- VNDA N/A
- BRT 6.34%
- EPS Growth
- VNDA N/A
- BRT N/A
- EPS
- VNDA N/A
- BRT N/A
- Revenue
- VNDA $201,351,000.00
- BRT $98,162,000.00
- Revenue This Year
- VNDA $16.86
- BRT $0.36
- Revenue Next Year
- VNDA $39.78
- BRT $5.65
- P/E Ratio
- VNDA N/A
- BRT N/A
- Revenue Growth
- VNDA 13.37
- BRT 2.71
- 52 Week Low
- VNDA $3.81
- BRT $14.61
- 52 Week High
- VNDA $6.37
- BRT $20.22
- Technical
- Relative Strength Index (RSI)
- VNDA 53.76
- BRT 47.07
- Support Level
- VNDA $4.49
- BRT $15.68
- Resistance Level
- VNDA $4.63
- BRT $16.16
- Average True Range (ATR)
- VNDA 0.14
- BRT 0.42
- MACD
- VNDA 0.00
- BRT -0.02
- Stochastic Oscillator
- VNDA 50.00
- BRT 21.57
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.